Shigehiro Yokoi

2PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 04, 2026
First- Versus Second- or Subsequent-Line Use of Cyclin-Dependent Kinase 4/6 Inhibitors for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic or Recurrent Breast Cancer: A Multicenter, Retrospective Cohort Study.

|Jun 01, 2019
Double primary recurrent human epidermal growth factor receptor 2-positive breast cancer and esophageal cancer that responded well to chemotherapy.

Shigehiro Yokoi, Hiroyuki Maeda, Takuma Nishino

Pageof 1

Frequent Collaborators

1 joint publications

Shoko Yao

1 joint publications

Shigeru Imoto

1 joint publications

Hirohito Seki

1 joint publications

Sota Asaga